VA Class:DE200
ATC Class:D07AB08
Desonide is a synthetic corticosteroid.
Desonide shares the actions of the other topical corticosteroids and is used for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses.
Topical preparations of desonide are applied sparingly in thin films and are rubbed gently into the affected area 2-4 times daily. Occlusive dressings may be used for severe or resistant dermatoses.
Desonide is a synthetic corticosteroid. The drug occurs as small plates or a white to off-white powder and is insoluble in water.
Desonide preparations should be stored in tight containers at a temperature less than 30°C; freezing should be avoided.
Additional Information
For further information on chemistry, pharmacology, absorption, uses, cautions, methods of application, and use of occlusive dressings in therapy with desonide, see the Topical Corticosteroids General Statement 84:06.08.
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
Please refer to the ASHP Drug Shortages Resource Center for information on shortages of one or more of these preparations.
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|---|---|---|---|
Topical | Cream | 0.05%* | Desonide Topical Cream | |
DesOwen® | Galderma | |||
Tridesilon® | Clay-Park | |||
Lotion | 0.05%* | Desonide Topical Lotion | ||
DesOwen® | Galderma | |||
Ointment | 0.05%* | Desonide Topical Ointment | ||
DesOwen® | Galderma | |||
Tridesilon® | Clay-Park |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
